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Background: Multiple epiphyseal dysplasia (MED) is a relatively common skeletal dysplasia mainly involving the
epiphyses of the long bones. However, it is a genetically heterogeneous group of diseases sharing certain aspects
of the radiologic phenotype. In surveys conducted in East Asia, MATN3 was the most common causative gene,
followed by COMP. In this study, the authors compared clinical manifestation of MED patients caused by MATN3
and COMP gene mutations, as well as subsequent orthopaedic interventions.
Methods: Fifty nine molecularly-confirmed MED patients were subjects of this study. The MATN3 gene mutation
group comprised of 37 patients (9 female, 28 male). The COMP gene mutation consisted of 22 cases (15 females,
7 males). Medical records and radiographs were reviewed, and questionnaire surveys or telephone interviews were
conducted.
Results: At the first presentation, the mean age was 8.8 ± 2.8 years (mean ± standard deviation) in the MATN3
group, and 8.5 ± 3.5 years in the COMP group (p = 0.670). The height in the COMP group was significantly shorter
than those in the MATN3 group (p < 0.001). Gait abnormality at the first visit (p = 0.041) and the lastest follow-up
(p = 0.037) were statistically significant difference. Hip pain (p = 0.084), limitation of daily activity (p = 0.075) at the
latest follow-up tended to be more frequent in the COMP group. Hip dysplasia was more common in the COMP
group, having significantly larger acetabular angle (p = 0.037), smaller center-edge angle (p = 0.002), severe Stulberg
classification (p < 0.001), and smaller femoral head coverage (p < 0.001).
Conclusions: Clinical manifestations of MED caused by MATN3 were milder than manifestations of the COMP
mutation group. These differences in clinical manifestation and prognosis justify molecular differentiation between
the two genotypes.
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Multiple epiphyseal dysplasia (MED) is a relatively com-
mon skeletal dysplasia mainly involving the epiphyses of
long bones. MED clinically manifests as mild short stature,
intermittent joint pain, angular or rotational deformity of
the extremities, short hands and feet, and/or precocious
osteoarthritis. Radiologic characteristics include delayed* Correspondence: tjcho@snu.ac.kr
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unless otherwise stated.ossification, hypoplasia and irregularity of long bone
epiphyses, and varying degrees of flattening of vertebral
bodies [1]. It is considered to represent a continuous
spectrum of severity [2]. MED is a genetically heteroge-
neous group of diseases sharing common radiologic
and clinical phenotypes. Mutations of the gene encoding
cartilage oligomeric matrix protein (COMP), matrilin-3
(MATN3), and alpha 1–3 chains of type IX collagen
(COL9A1, COL9A2, COL9A3) are responsible for MED
inherited as an autosomal dominant trait, [3] whereas mu-
tations at the gene encoding diastrophic dysplasia sulfate. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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MED inherited as an autosomal recessive trait [4,5]. Some
patients with clinical and radiographic phenotype of MED
do not have mutations in these genes, [3,6-8] suggesting
presence of causative genes other than these 6 genes.
Studies of Caucasian and East Asian populations
showed ethnic differences in the distribution of causative
genes for MED. In an early study on Caucasian popula-
tion reported the proportions of DTDST as 14%, COMP
as 10%, MATN3 as 10%, and unknown as 66% in 29
MED patients [7]. Subsequent studies reported that
COMP (47% and 50%) was the most common causative
gene followed by DTDST (25% and 28%), while MATN3
(17%) and COL9A1, 2, and 3 (8%) comprised only a
small portion of these MED patients [3,9]. On the other
hand, studies on Korean [8] and Japanese [6] popula-
tions indicated that MATN3 was the most common
causative gene, comprising 54.5% and 47.4% of MED pa-
tients with known genotype, followed by COMP muta-
tions (41.8% and 36.8%, respectively). Type IX collagen
genes and DTDST represented around 10% or less.
Individual clinical and radiographic characteristics of
MEDs caused by COMP, MATN3, type IX collagenFigure 1 Radiographic features of COMP-MED (A, B, C) and of MATN3
round femoral heads with irregular acetabular roof. B: At 12 years, the epip
radiograph shows brachymetacarpals, small and irregular carpal bones and di
shape femoral head with fragmentation and smooth acetabular roof. E: At 11
along with irregular and flattened epiphysis. F: At age 6 years, the hand radiog
is partly a citation for images taken from “Revisit of Multiple Epiphyseal Dyspla
Features Linked to the COMP and MATN3 Genes” of the American Journal of
11:2669–2680 with permission).genes or DTDST have been described [3,10-14]. Con-
sidering the incidence of each genotype of MED in
East Asian populations, it is important to differentiate
between the most common genotypes of MED – MATN3-
MED (EDM5, MIM#607078) versus COMP-MED (EDM1,
MIM#132400). Investigations on radiographic characteris-
tics of MATN3-MED versus COMP-MED have allowed
for radiographic differentiation between these two entities
(Figure 1) [3,8]. However, clinical characteristics and prog-
nosis have not been elucidated for these two genotypes of
MED. The purpose of this study was to compare ortho-
paedic manifestations of MED caused by MATN3 versus
COMP mutations and to subsequently delineate the impli-
cation of genotypes in MED.
Methods
This retrospective study was approved by the institu-
tional review board at Seoul National University Hos-
pital. Fifty-nine MED patients, who were molecularly
confirmed to have either MATN3 or COMP mutations,
were subjects in this study.
The MATN3 group was comprised of 37 subjects
(9 female, 28 male). Thirty patients were probands, and-MED (D, E, F). A: At 6 years of age, hip radiograph shows small and
hysis at the knee joint is irregular and flattened. C: At 6 years, the hand
stal radial epiphysis. D: At 6 years, the hip radiograph shows crescent
years of age, the vertical striations at the metaphysis are conspicuous
raph shows no brachymetacarpals or carpal bone irregularity. (This figure
sia: Ethnic Difference in Genotypes and Comparison of Radiographic
Medical Genetics Part A. It is in the Nov 2011, Volume 155A, Issue
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7 probands. They harbored 7 different mutations in the
MATN3 gene as previously reported [8]. The most com-
mon mutation was c.361C > T (p.R121W), present in 27
out of the 37 patients in the MATN3 group.
The COMP group was comprised of 22 subjects (15
female, 7 male). Twenty patients were probands, and the
remaining 2 subjects were affected family members of 2
probands. They harbored 16 different mutations in the
COMP gene as previously reported [8]. The mean
follow-up period was 4.0 ± 3.9 years (mean ± standard
deviation) for the MATN3 group and 6.6 ± 5.3 years for
the COMP group.
Medical records were reviewed. Data at the first pres-
entation were recorded, including age, gender, chief
complaint, presence or absence of joint pain, and gait
abnormalities (waddling, in-toeing, or out-toeing). The
most concerning symptom at first presentation was se-
lected as the chief complaint. Data at latest follow-upFigure 2 Sequential radiographic change of AVN in an MATN3-MED p
age. B: Resorption phase at 10 years. C: Resossification phase at 12 years. Dwere recorded, including height, presence or absence of
joint pain, and gait abnormality. Height was converted
into z-score using age-matched reference data of the same
ethnic group. The patients were asked as to whether the
current symptom(s) interfered with their daily life.
Sequential radiographic studies of hip joints were eval-
uated for occurrences of avascular necrosis (AVN) of the
femoral head and of aberrant development of the hip
joint. AVN was defined as 1) sequential radiographic
change of all or part of stages including sclerosis, sub-
chondral crescent sign, resorption of the preexisting
bone tissue, and re-ossification (Figure 2), and 2) associ-
ated painful limitation of hip joint motion during active
phase. Symmetrical appearance of fragmented or aber-
rantly ossified femoral head without subsequent changes
of avascular necrosis and/or not associated with painful
limitation of hip motion was considered as aberrant de-
velopment of the hip, rather than avascular necrosis
(Figure 3).atient. A: Sclerotic femoral head and metaphyseal cyst at 9 years of
: Late reossification phase at age 15 years.
Figure 3 Aberrant hip development in a COMP-MED patient. A: At
3 years of age, the radiograph shows small and round femoral heads
and irregular acetabular roof. Through the puberty and adolescence
(B: At 11 years. C: At 12 years. D: At 13 years), the hips become
dysplastic, uncovered and of flattened and irregular femoral heads.
Table 1 Clinical manifestations at the first visit
MATN3 group COMP group p-value
Number of patients 37 22
Age (year) 8.8 ± 2.8* 8.5 ± 3.5* 0.670***
Hip pain 11 (29.7)** 6 (27.3)** 0.844+
Knee pain 13 (35.1)** 10 (45.5)** 0.441+
Ankle pain 3 (8.1)** 4 (18.2)** 0.300++
Back pain 0 (0)** 0 (0)** 1.000++
Gait abnormality 15 (40.5)** 15 (68.2)** 0.041+
*Mean ± standard deviation, **number of patients (percentile).
***student's t-test, +Pearson’s chi-square test, ++Fisher’s exact test.
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oral head coverage, acetabular angle (AA), [15] center-
edge angle (CEA), [16] Stulberg classification, [17] and
femoral head coverage [18,19] were measured on the lat-
est radiograph or on the radiograph taken just before any
operation that would have changed these parameters. For
statistical analysis, one hip was randomly selected on ra-
diographs taken over 10 years of age. Twenty-seven pa-
tients in the MATN3 group were included in this analysis,
whose median age was 14 years (range, 10 to 41 years),
and sixteen patients in the COMP group, whose median
age was 14 years (range, 15 to 46 years).
Type and purpose of the surgical intervention were
categorized and recorded.Age at the first visit of probands was compared be-
tween the two groups using student’s t-test. Categorical
parameters were analyzed using Pearson’s Chi-square
test when all the cells had frequency more than 5, or
using Fisher’s exact test when any cell had frequency of
5 or less. Distribution of head deformity according to
the Stulberg classification was compared using linear by
linear association test. The z-score for height, AA, CEA,
femoral head coverage, and number of surgical proce-
dures were compared by the Mann–Whitney test. Vari-
ance of height and radiographic parameters were
compared between the two groups using Levene’s test. A
p-value less than 0.05 was considered as statistically
significant.
Results
The mean age at first presentation was 8.8 ± 2.8 years
(mean ± SD) in the MATN3 group and 8.5 ± 3.5 years in
the COMP group (p = 0.670). Chief complaints included
gait abnormality, knee angular deformities, pain at the
hip, knee, or ankle joints, and short stature. In the
MATN3 group, pain at the knee joint was the most
common chief complaint, followed by pain at the hip
joint, genu valgum deformity, and gait abnormality in
decreasing order of frequency. In the COMP group, gait
abnormality was the most common chief complaint,
followed by hip pain and knee pain. There were no sta-
tistically significant differences in proportions of chief
complaints between the two groups. Of the clinical man-
ifestations detected by interview or physical examination
at the first visit, gait abnormality was significantly more
common in the COMP group than in the MATN3 group
(p = 0.041), but incidences of various types of pain were
not significantly different between the two groups
(Table 1).
At the latest follow-up, persistent gait abnormality was
significantly more common in the COMP group than in
the MATN3 group. Persistent hip pain and limitation of
daily activity tended to be more common in the COMP
group than in the MATN3 group, although it was not
statistically significant. However, the prevalence of pain
Figure 4 Comparison of height between MATN3 and COMP
groups. Zero on the Y-axis denotes age and gender-matched
average height.
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ent between the two groups (Table 2).
Patients in the COMP group were significantly shorter
than those in the MATN3 group (p < 0.001) (Figure 4).
All the COMP-MED patients were below average in
height, while twelve of 37 MATN3-MED patients were
above average for their age and gender. The heights of
these 12 patients range from the 50th to 89th centiles
(z-value 0.02 to 1.23) of the ethnicity-specific age/gender
matched normal population. The COMP group showed
wider height distribution than the MATN3 group, al-
though it was not statistically significant (p = 0.057).
According to the criteria described above, AVN of the
femoral head had occurred in 4 of 37 (10.8%) MATN3-
MED patients, and 1 of 22 (4.5%) COMP-MED patients
(p = 0.641). On the other hand, aberrant development of
the hip was commonly observed in the COMP group, but
most MATN3-MED patients developed with normal-
appearing hip joints unless complicated by the AVN.
Among patients older than 10 years, the COMP-MED
patients exhibited more dysplastic hip joints. AA was
significantly larger in the COMP group (median 50°,
range 35° - 56°, standard error of the mean[SEM] 1.7)
than in the MATN3 group (median 44°, range 34° - 52°,
SEM 0.9) (p = 0.037), and CEA was significantly smaller in
the COMP group (median 8°, range −22° to 40°, SEM 3.7)
than in the MATN3 group (median 23°, range 6° to 36°,
SEM 1.4) (p = 0.002) (Figure 5). Femoral head coverage
was smaller in the COMP group (median 0.58, range 0.16
to 0.92, SEM 0.04) than in the MATN3 group (median
0.79, range 0.57 to 0.94, SEM 0.02) (p < 0.001) (Figure 5).
The variances of CEA and femoral head coverage were
significantly larger in the COMP group than in the
MATN3 group (p = 0.031 and p = 0.048, respectively).
And the COMP group was more diverse in AA, but it was
not statistically significant (p = 0.080). According to the
Stulberg classification, the severity of hip deformity was
significantly worse in the COMP group than in the
MATN3 group (p < 0.001) (Table 3).Table 2 Clinical manifestations at the latest follow-up
MATN3 group COMP group p-value
No. of patients 37 22
Follow-up (year) 3.7 ± 3.9* 6.6 ± 5.2*
Hip pain 3 (8.1)** 6 (27.3)** 0.084+
Knee pain 7 (18.9)** 5 (22.7)** 0.748+
Ankle pain 2 (5.4)** 1 (4.5)** 0.887+
Back pain 1 (2.7)** 0 (0)** 0.445+
Gait abnormality 4 (10.8)** 8 (36.4)** 0.037+
Limitation of daily activity 4 (10.8)** 7 (31.8)** 0.075+
*Mean ± standard deviation, **number of patients (percentile).
+Fisher’s exact test.A total of 76 surgical procedures were performed in
37 MATN3-MED patients, and 62 procedures in 22
COMP-MED patients. Correction of angular deformity
at the knee joint was the most commonly performed
procedure. Hemiepiphyseal suppression using stapling or
percutaneous epiphysiodesis using transphyseal screw
(PETS) were performed for growing children, while
acute correction by osteotomy or gradual correction by
distraction osteogenesis were reserved for the skeletally
mature patients (Table 4). Hip procedures performed in-
clude shelf acetabuloplasty, proximal femoral osteotomy,
Chiari osteotomy, triple osteotomy of the pelvis, and soft
tissue release. The COMP-MED patients underwent sig-
nificantly more hip surgeries than the MATN3-MED pa-
tients (p = 0.034) (Table 4).
Discussion
This study compared clinical and radiological character-
istics of MED caused by MATN3 mutations versus
COMP mutations, from an orthopaedic point of view.
Characteristics of various MED genotypes have been de-
scribed in a small number of patients or in families
[3,12-14,20-22]. However, this was the first study that
statistically analyzed differences in clinicoradiographic
features in substantial numbers of molecular-confirmed
MATN3-MED versus COMP-MED patients.
The clinical characteristic of MATN3-MED has only
been reported in studies of a single family [12,21,22] or
a small number of patients [22]. In these studies, the in-
vestigators described MATN3-MED patients as having
slightly short or normal stature, complaints in early
childhood at knee and hip joints, and early onset osteo-
arthritis [3,12,22]. The current study confirmed that
Figure 5 Comparisons of radiographic parameters for hip dysplasia. A: Acetabular angle. B: Center-edge angle. C: Femoral head coverage.






Number of patients in the group 37 22
Number of patients having operation 15 (40.5%) 13 (59.1%) 0.168*
Number of surgical procedures 76 62 0.117*
For angular deformity at the knee 38 27 0.542*
Hemiepiphyseal suppression 34 16
Acute correction by osteotomy 2 6
Ilizrov method 2 5
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and are significantly taller in comparison to COMP-
MED patients (Figure 4). The MATN3 group demon-
strated a significantly lower incidence of gait abnormal-
ity throughout the follow-up period, and patients were
less likely have complaints of hip pain and limitation of
daily activity at latest follow-up. Accordingly, our find-
ings suggest that the MATN3 mutation results in rela-
tively milder phenotypes as compared with those of
COMP mutation. In contrast, COMP-MED is an allelic
disease of pseudoachondroplasia (PSACH; MIM#177170),
which is a more severe disease in the spectrum of COMP-
pathy. Hence, it is likely that COMP-MED constitutes a
spectrum from mild to severe MED cases. Our data also
showed significantly more diverse CEA and femoral head
coverage in the COMP group.
Orthopaedic intervention is frequently indicated in pa-
tients with MED. In this series, correction of angular de-
formity at the knee joint was the most common surgical
procedure for MED, without significant differences be-
tween groups (Table 3). During childhood, hemiepiphy-
seal suppression by stapling, [23] PETS, [24] or guided
growth should be effective in correction of the angular
deformity around the knee joint. Angular deformity cor-
rection improves biomechanics and external appearance
of the knees. However, these procedures do not guaran-
tee prevention of early onset osteoarthritis of the knee
because the cartilage matrix defect originates fromTable 3 Stulberg classification of acetabulum and femoral
head






*Linear by linear association test shows significant difference between the two
groups (p < 0.001).
For statistical analysis, only one side of the hip was selected randomly on
radiographs taken over 10 years of age.mutations of either MATN3 or COMP. Due to the mul-
ticenter nature of this study, selection of surgical proce-
dures depended largely on operator preference in this
series.
Surgical intervention at the hip joints was less com-
mon than at the knee joints, but the prognosis for hip
joints seems to be more guarded, especially in COMP-
MED patients. The knee joint surgeries were angular de-
formity correction procedures with straightforward out-
come. On the other hand, the hip surgeries were to
improve hip joint function in AVN or hip dysplasia sec-
ondary to aberrant hip development, in order to in-
crease the femoral head coverage or containment,
however the efficacy has yet to be determined. In our
series, AVN occurred in both groups. MATN3-MED
patients, who showed abnormal radiographic findingsFor rotation deformity 0 1 0.373+
FDO 0 1
Hip surgery for coverage/containment 6 15 0.034*
Shelf acetabuloplasty 2 5
FVDO 3 3
Chiari osteotomy 0 1
Triple innominate osteotomy 0 1
Soft tissue release 1 3
Implant removal 32 19 0.776*
FDO: femoral derotation osteotomy, FVDO: femoral varization-derotation
osteotomy.
*Mann-Whitney test, +Fisher’s exact test.
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oped normal-appearing hip joints unless complicated
by AVN. On the other hand, many COMP-MED pa-
tients showed persistent aberrant hip development, and
ended up with deformed and sometimes subluxated hip
joints, which may keep the hip joints symptomatic,
even at adolescence. This difference is reflected by the
significant difference in the frequency of hip surgery
between the two groups (Table 4). However, it is note-
worthy that hip and knee joint pain complaints during
childhood are not necessarily associated with AVN, but
are more likely to be transient in nature and usually
subside with conservative management.
Abnormal appearance of the femoral head in MED is
sometimes confused with AVN, and genuine AVN also
develops in MED patients, which should be strictly dif-
ferentiated from the MED itself. Mackenzie et al. re-
ported a series of AVN associated MED [25]. From
that report, we would suggest the diagnostic criteria of
AVN in MED as: 1) a new onset of clinical symptoms
of limping, pain at groin, thigh or knee, limitation of
hip motion, particularly abduction and internal rotation;
2) sequential radiographic changes of AVN, including
sclerosis, subchondral “crescent” sign, resorption of exist-
ing bone tissue, and reossification process along with
metaphyseal cyst or widening; 3) unilateral or asynchron-
ous involvement; 4) documentation of cold spot at pre-
viously ossified areas of the femoral head on bone
scintigraphy before resorption phase; or 5) MRI find-
ings compatible with AVN. However, many MED pa-
tients show abnormal hip development which is not
compatible with the above criteria for AVN. These ab-
normalities include irregular and steep acetabular roof,
persistent fragmentation or mottling of the femoral
head, flattened femoral capital epiphysis, and eventual
deformation of the femoral head. We believe these do
not constitute cases of AVN, but of aberrant hip devel-
opment from skeletal dysplasia.
This study has several limitations. It was designed as a
retrospective multicenter study, and clinical manifesta-
tions could only be categorized on an all-or-none basis,
instead of more a sophisticated standardized scoring sys-
tem. Most patients have not reached skeletal maturity at
the latest follow-up; hence, this study represents interim
follow-up results. Nevertheless, the study was able to
demonstrate significant differences in clinical character-
istics between MATN3-MED and COMP-MED.
Although MATN3-MED and COMP-MED are cur-
rently categorized under the same clinical diagnosis of
MED, the long term prognosis of the joints, especially
hip joint, should be different. Unless complicated by
AVN, MATN3-MED patients are expected to develop
normal appearing hips at skeletal maturity. In contrast,
COMP-MED patients seem to experience more clinicalsymptoms in childhood, and are more likely to develop
early onset osteoarthritis of the hip due to aberrant
development.
Conclusion
In comparison between MATN-3 and COMP-MED, the
COMP-MED patients were shorter in height, and had
more gait abnormality and hip dysplasia, while the
MATN3-MED patients had a relatively milder pheno-
type from an orthopaedic point of view. These differ-
ences in clinical manifestation and prognosis justify
distinguishing between the COMP and MATN3 molecu-
lar subtypes of MED.
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